iRay Technology Hits Day Low of CNY 103.50 Amid Price Pressure

iRay Technology Co., Ltd. experienced a notable decline today, with the stock dropping by 5.16% to touch an intraday low of CNY 103.50. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.09% on the same day. Over the past week, iRay has seen a more significant downturn, with a total decline of 8.18%, and a 13.41% drop over the past month. Despite a strong performance over the past year, where the stock generated a return of 32.61%, recent trends indicate challenges. The company has reported negative results for the last three consecutive quarters, and its net sales growth has slowed to an annual rate of 23.97%. Additionally, the rising raw material costs, which increased by 102.8% year-over-year, have contributed to the company's financial pressures. With a market capitalization of CNY 24,130 million, iRay Technology operates within the Pharmaceuticals & Biotechnology sector. The stock's current price-to-book ratio stands at 4.69, reflecting a high valuation relative to its book value.